Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...

A team of doctors in Mumbai treated a 24-year-old engineering student who was suffering from multiple sclerosis, a chronic disease that affects the nervous system. For the patient, Sushant Chavan, ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

When he was 25, he learned that he had multiple sclerosis. He coped with the disease throughout a long career at several ...

"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

After getting through a significant difficulty, many of us reject being described in favorable terms. Why don't we want to ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Richard Cohen, a respected journalist and the husband of former “Today” show anchor Meredith Vieira, ... Read More ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...